Melatonin/Cyclodextrin Inclusion Complexes: A Review
Melatonin (MLT) is involved in many functions of the human body, mainly in sleeping-related disorders. It also has anti-oxidant potential
Tag: Parkinson disease
Lippia grata essential oil complexed with β-cyclodextrin ameliorates biochemical and behavioral deficits in an animal model of progressive parkinsonism
Parkinson’s disease (PD) is identified by the loss of dopaminergic neurons in the Substantia Nigra pars compacta (SNpc), and is
HPBCD for Treatment of Parkinson Disease
The recent work of Jarazo et al. demonstrates that HP-β-CD ameliorates the dopaminergic neuronal loss phenotype, confirming the therapeutic potential
Parkinson’s Disease Phenotypes in Patient Neuronal Cultures and Brain Organoids Improved by 2-Hydroxypropyl-β-Cyclodextrin Treatment
OrganoTherapeutics in collaboration with University of Luxemburg has published interestingin vitro and in vivo results on the effects of HPBCD
Caffeine, a natural methylxanthine nutraceutical, exerts dopaminergic neuroprotection
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that affects more than 10 million people worldwide. Oxidative stress and mitochondrial
Central nervous system delivery of molecules across the blood-brain barrier
Therapies targeting neurological conditions such as Alzheimer’s or Parkinson’s diseases are hampered by the presence of the blood-brain barrier (BBB).
Press Release – Development of Autophagy Inducing Cyclodextrin Derivatives for Aging-associated Diseases
CycloLab Cyclodextrin R&D Ltd. proudly announces winning of a national grant about the development of cyclodextrin-dervatives for autophagy-associated neurodegenerative diseases.
International Conference on Alzheimer’s Disease & Dementia
International Conference on Alzheimer’s Disease & Dementia is scheduled Hilton Rome Airport ,Rome, Italy from July 20 – 22, 2020. This International Conference